BROOMFIELD, Colo. — Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Aclarion is scheduled to present on Tuesday, October 20, 2026 at 11:30 AM PT. Brent Ness, Chief Executive Officer will represent […]
CATEGORY: Press Release
New criteria fully approved at nine of eleven active sites expected to significantly accelerate enrollment pace Initial readout timing to be updated by year-end based on demonstrated Q4 enrollment increases Overall trial duration remains on track BROOMFIELD, Colo. — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging […]
NYU Langone Health is a nationally recognized academic medical center with deep expertise in spine surgery, minimally invasive procedures, robotic spine surgery, and clinical research CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying […]
University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical research and innovation Ten sites now actively enrolling in CLARITY study, a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical […]
Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflow Designed to reduce scan time, support faster technologist onboarding and deliver more reproducible results across imaging centers Extends Aclarion’s IP protection to over 65 issued and pending patents worldwide, complementing its broader portfolio covering spectroscopy […]
Partnership brings Nociscan for chronic low back pain to one of the nation’s leading neurosurgery and spine care networks Goodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training and clinical research Availability of Nociscan in Indiana reflects Company’s focus on expansion and adding to its growing base of provider sites […]
Dear Fellow Shareholders, The first half of 2026 marked an important period of execution and momentum for Aclarion. We entered the year focused on three priorities: accelerating clinical adoption of Nociscan®, advancing reimbursement and evidence generation milestones, and maintaining the financial discipline required to deliver on our value creating catalysts. At midyear, we continue to […]
141% year-over-year scan volume growth in first half of 2026 Reimbursement momentum in the U.K. translating into consistent scan volume growth Launched Market Access Program in partnership with PRIA Healthcare to secure insurance coverage for Nociscan in the U.S. Continued progress toward the CLARITY trial readout with the addition of multiple new trial sites Strengthened […]
Abstracts presented at American Society of Pain & Neuroscience (ASPN) annual meeting across surgical decision support and basivertebral nerve ablation Early findings from real-world evidence study demonstrate immense utility and ability of Nociscan to be incorporated into clinical practice Case study represents first reported use of Nociscan to guide basivertebral nerve ablation in a patient […]
Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient’s pain before recommending treatment CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources […]
Request Info or Schedule a Demo
"*" indicates required fields
Aclarion
8181 Arista Place,
Suite 100
Broomfield, CO 80021
